MENU
Aim higher

BIOSTAR17

A novel diagnostic Biosensor for ALK-targeted therapy of non-small cell lung cancer (NSCLC)

Start date: 
01-10-2017
Project Duration: 
0months
Technological Area: 
In vitro Testing, Trials
Market Area: 
Diagnostic test products and equipment